Fiduciary Trust’s Foundation Medicine, Inc. FMI Stock Holding History

Fiduciary Trust’s Portfolio FMI Stock Details FMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,000	Closed	-$236K	–	461
2018 Q1	$236K	Hold	3,000	–	–	0.01%	416
2017 Q4	$205K	Buy	+3,000	New	+$156K	0.01%	424
2017 Q3	–	Sell	-3,000	Closed	-$119K	–	529
2017 Q2	$119K	Buy	+3,000	New	+$110K	﹤0.01%	510

Other funds holding FMI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Fiduciary Trust's FMI Position: Q2 2018 in Review

Fiduciary Trust sold out of Foundation Medicine, Inc. (FMI) in Q2 2018, closing a stake of 3,000 shares — an estimated $236K sold.

Fiduciary Trust first reported a position in FMI in Q2 2017 and held it in 3 quarters. The position peaked at $236K in Q1 2018. 157 funds tracked by Wall St. Rank hold FMI as of Q2 2018.

Fiduciary Trust reported no remaining Foundation Medicine, Inc. position as of Q2 2018 after selling out during the quarter.
Fiduciary Trust sold 3,000 Foundation Medicine, Inc. shares in Q2 2018, an estimated $236K.
Fiduciary Trust first reported a position in Foundation Medicine, Inc. in Q2 2017 and held it in 3 quarters.
Fiduciary Trust's Foundation Medicine, Inc. position peaked at $236K in Q1 2018.
157 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q2 2018.

Based on Fiduciary Trust's 13F filing for Q2 2018, filed 3 Aug 2018.